These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2616898)

  • 21. Effect of tyrosine on the potentiation by aspartame and phenylalanine of metrazol-induced convulsions in rats.
    Guiso G; Diomede L; Romano M; Caccia S; Sarati S; Salmona M
    Food Chem Toxicol; 1991 Dec; 29(12):855-7. PubMed ID: 1765332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.
    Magnuson BA; Burdock GA; Doull J; Kroes RM; Marsh GM; Pariza MW; Spencer PS; Waddell WJ; Walker R; Williams GM
    Crit Rev Toxicol; 2007; 37(8):629-727. PubMed ID: 17828671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Aspartame as a sweetener.
    Olney JW
    N Engl J Med; 1975 Jun; 292(23):1244-5. PubMed ID: 1128585
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of aspartame and aspartate loading upon plasma and erythrocyte free amino acid levels in normal adult volunteers.
    Stegink LD; Filer LJ; Baker GL
    J Nutr; 1977 Oct; 107(10):1837-45. PubMed ID: 903828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease.
    Hertelendy ZI; Mendenhall CL; Rouster SD; Marshall L; Weesner R
    Am J Gastroenterol; 1993 May; 88(5):737-43. PubMed ID: 8480740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of aspartame and glucose administration on brain and plasma levels of large neutral amino acids and brain 5-hydroxyindoles.
    Yokogoshi H; Roberts CH; Caballero B; Wurtman RJ
    Am J Clin Nutr; 1984 Jul; 40(1):1-7. PubMed ID: 6204522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interspecies and interstrain studies on the increased susceptibility to metrazol-induced convulsions in animals given aspartame.
    Diomede L; Romano M; Guiso G; Caccia S; Nava S; Salmona M
    Food Chem Toxicol; 1991 Feb; 29(2):101-6. PubMed ID: 2010138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral assessment of the toxicity of aspartame.
    Holder MD; Yirmiya R
    Pharmacol Biochem Behav; 1989 Jan; 32(1):17-26. PubMed ID: 2734328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proconvulsant effect of papaverine on theophylline-induced seizures in rats.
    Ramzan I
    Clin Exp Pharmacol Physiol; 1989 May; 16(5):425-7. PubMed ID: 2766582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis of FDA passive surveillance reports of seizures associated with consumption of aspartame.
    Tollefson L; Barnard RJ
    J Am Diet Assoc; 1992 May; 92(5):598-601. PubMed ID: 1573143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of developmental effects in CF-1 mice exposed to aspartame in utero.
    McAnulty PA; Collier MJ; Enticott J; Tesh JM; Mayhew DA; Comer CP; Hjelle JJ; Kotsonis FN
    Fundam Appl Toxicol; 1989 Aug; 13(2):296-302. PubMed ID: 2792596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeine as a potential risk factor for theophylline neurotoxicity.
    Yasuhara M; Levy G
    J Pharm Sci; 1988 Sep; 77(9):745-7. PubMed ID: 3225766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of chronic caffeine administration on theophylline concentrations required to produce seizures in rats.
    Zhi JG; Levy G
    Proc Soc Exp Biol Med; 1990 Mar; 193(3):210-3. PubMed ID: 2304923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of drug action in disease states. XX. Effects of acute starvation on the pharmacodynamics of phenobarbital, ethanol and pentylenetetrazol in rats and effects of refeeding and diet composition.
    Wanwimolruk S; Levy G
    J Pharmacol Exp Ther; 1987 Jul; 242(1):166-72. PubMed ID: 3612521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of orally administered dextromethorphan on theophylline- and pentylenetetrazol-induced seizures in rats.
    Zhi JG; Levy G
    J Pharm Sci; 1990 Dec; 79(12):1053-5. PubMed ID: 2079649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspartame: clinical update.
    Potenza DP; el-Mallakh RS
    Conn Med; 1989 Jul; 53(7):395-400. PubMed ID: 2667892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic sweetners: cyclamates, saccharin, aspartame.
    Med Lett Drugs Ther; 1975 Jul; 17(15):61-2. PubMed ID: 1152816
    [No Abstract]   [Full Text] [Related]  

  • 39. Biological properties of aspartame. I. Evaluation of central nervous system effects.
    Potts WJ; Bloss JL; Nutting EF
    J Environ Pathol Toxicol; 1980; 3(5-6):341-53. PubMed ID: 7441089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of oral or parenteral aspartame on catecholamine metabolism in various regions of rat brain.
    Yokogoshi H; Wurtman RJ
    J Nutr; 1986 Mar; 116(3):356-64. PubMed ID: 3950762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.